PMC:7102599 / 13-377 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"2","span":{"begin":43,"end":48},"obj":"Gene"},{"id":"3","span":{"begin":32,"end":42},"obj":"Species"},{"id":"25","span":{"begin":293,"end":297},"obj":"Gene"},{"id":"28","span":{"begin":174,"end":179},"obj":"Gene"},{"id":"29","span":{"begin":97,"end":107},"obj":"Species"},{"id":"30","span":{"begin":162,"end":173},"obj":"Species"},{"id":"31","span":{"begin":275,"end":285},"obj":"Species"},{"id":"32","span":{"begin":354,"end":364},"obj":"Species"},{"id":"44","span":{"begin":132,"end":142},"obj":"Disease"},{"id":"45","span":{"begin":154,"end":160},"obj":"Disease"}],"attributes":[{"id":"A2","pred":"tao:has_database_id","subj":"2","obj":"Gene:43740568"},{"id":"A3","pred":"tao:has_database_id","subj":"3","obj":"Tax:2697049"},{"id":"A25","pred":"tao:has_database_id","subj":"25","obj":"Gene:59272"},{"id":"A28","pred":"tao:has_database_id","subj":"28","obj":"Gene:43740568"},{"id":"A29","pred":"tao:has_database_id","subj":"29","obj":"Tax:2697049"},{"id":"A30","pred":"tao:has_database_id","subj":"30","obj":"Tax:11118"},{"id":"A31","pred":"tao:has_database_id","subj":"31","obj":"Tax:2697049"},{"id":"A32","pred":"tao:has_database_id","subj":"32","obj":"Tax:2697049"},{"id":"A44","pred":"tao:has_database_id","subj":"44","obj":"MESH:D007239"},{"id":"A45","pred":"tao:has_database_id","subj":"45","obj":"MESH:D003643"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"nction, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein\n\nAbstract\nSummary\nThe emergence of SARS-CoV-2 has resulted in \u003e90,000 infections and \u003e3,000 deaths. Coronavirus spike (S) glycoproteins promote entry into cells and are the main target of antibodies. We show that SARS-CoV-2 S uses ACE2 to enter cells and that the receptor-binding domains of SARS-CoV-2"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T1","span":{"begin":49,"end":61},"obj":"Body_part"},{"id":"T2","span":{"begin":184,"end":197},"obj":"Body_part"},{"id":"T3","span":{"begin":217,"end":222},"obj":"Body_part"},{"id":"T4","span":{"begin":307,"end":312},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"fma_id","subj":"T1","obj":"http://purl.org/sig/ont/fma/fma62925"},{"id":"A2","pred":"fma_id","subj":"T2","obj":"http://purl.org/sig/ont/fma/fma62925"},{"id":"A3","pred":"fma_id","subj":"T3","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A4","pred":"fma_id","subj":"T4","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"nction, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein\n\nAbstract\nSummary\nThe emergence of SARS-CoV-2 has resulted in \u003e90,000 infections and \u003e3,000 deaths. Coronavirus spike (S) glycoproteins promote entry into cells and are the main target of antibodies. We show that SARS-CoV-2 S uses ACE2 to enter cells and that the receptor-binding domains of SARS-CoV-2"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T1","span":{"begin":32,"end":40},"obj":"Disease"},{"id":"T2","span":{"begin":97,"end":105},"obj":"Disease"},{"id":"T3","span":{"begin":132,"end":142},"obj":"Disease"},{"id":"T4","span":{"begin":275,"end":283},"obj":"Disease"},{"id":"T5","span":{"begin":354,"end":362},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A2","pred":"mondo_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A3","pred":"mondo_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A4","pred":"mondo_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A5","pred":"mondo_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"nction, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein\n\nAbstract\nSummary\nThe emergence of SARS-CoV-2 has resulted in \u003e90,000 infections and \u003e3,000 deaths. Coronavirus spike (S) glycoproteins promote entry into cells and are the main target of antibodies. We show that SARS-CoV-2 S uses ACE2 to enter cells and that the receptor-binding domains of SARS-CoV-2"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T1","span":{"begin":108,"end":111},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T2","span":{"begin":217,"end":222},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T3","span":{"begin":307,"end":312},"obj":"http://purl.obolibrary.org/obo/GO_0005623"}],"text":"nction, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein\n\nAbstract\nSummary\nThe emergence of SARS-CoV-2 has resulted in \u003e90,000 infections and \u003e3,000 deaths. Coronavirus spike (S) glycoproteins promote entry into cells and are the main target of antibodies. We show that SARS-CoV-2 S uses ACE2 to enter cells and that the receptor-binding domains of SARS-CoV-2"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T1","span":{"begin":49,"end":61},"obj":"Chemical"},{"id":"T2","span":{"begin":184,"end":197},"obj":"Chemical"}],"attributes":[{"id":"A1","pred":"chebi_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_17089"},{"id":"A2","pred":"chebi_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CHEBI_17089"}],"text":"nction, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein\n\nAbstract\nSummary\nThe emergence of SARS-CoV-2 has resulted in \u003e90,000 infections and \u003e3,000 deaths. Coronavirus spike (S) glycoproteins promote entry into cells and are the main target of antibodies. We show that SARS-CoV-2 S uses ACE2 to enter cells and that the receptor-binding domains of SARS-CoV-2"}

{"project":"LitCovid-sentences","denotations":[{"id":"T2","span":{"begin":63,"end":71},"obj":"Sentence"},{"id":"T3","span":{"begin":72,"end":79},"obj":"Sentence"},{"id":"T4","span":{"begin":80,"end":161},"obj":"Sentence"},{"id":"T5","span":{"begin":162,"end":261},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"nction, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein\n\nAbstract\nSummary\nThe emergence of SARS-CoV-2 has resulted in \u003e90,000 infections and \u003e3,000 deaths. Coronavirus spike (S) glycoproteins promote entry into cells and are the main target of antibodies. We show that SARS-CoV-2 S uses ACE2 to enter cells and that the receptor-binding domains of SARS-CoV-2"}